Saventic Health, founded in 2019 and based in Warsaw, develops AI algorithms to assist clinicians in diagnosing rare diseases. Its technology analyzes medical records and currently has 50 algorithms in use, enabling diagnoses of over 200 individuals in the past year. Solutions are deployed globally through projects with 11 of the 30 largest pharmaceutical companies and more than 30 clinics and hospitals across Poland, Germany, France, Brazil, and Canada. The 40-member team of doctors, data scientists, and data engineers focuses on leveraging AI for healthcare innovation, with algorithms registered as medical devices across the EU and certified as medical products in parts of South America. The company says its approach identifies potential rare disease diagnoses more efficiently than traditional methods, which can take 7–12 years and have low success rates. Saventic is pursuing geographic expansion into additional European and South American markets and plans to enter the U.S. after completing a forthcoming Series A.

Total raised

$2M

Funding rounds

1

Latest round

Equity

Latest activity

Dec 2024